|4Sep 22, 8:20 PM ET

Arman Arvin Cyrus 4

4 · CytoDyn Inc. · Filed Sep 22, 2022

Insider Transaction Report

Form 4
Period: 2022-09-20
Transactions
  • Award

    Common Stock

    2022-09-20+646,552646,552 total
  • Award

    Non-qualified stock option (right to buy)

    2022-09-20+1,575,5571,575,557 total
    Exercise: $0.58Exp: 2032-09-20Common Stock (1,575,557 underlying)
Footnotes (2)
  • [F1]Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2012 Equity Incentive Plan, as amended (the "Plan"). The RSUs will vest in four (4) equal annual installments beginning July 9, 2023, subject to Continuous Service (as the term is defined in the Plan) through the applicable vesting date.
  • [F2]25% of the award will vest on July 9, 2023; thereafter, the balance will vest in 36 equal monthly installments, subject to Continuous Service (as the term is defined in the Plan) through the applicable vesting date.

Documents

1 file
  • 4
    tm2226067-4_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT